Waypoint Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.16M Buy
7,129
+362
+5% +$57.7K 0.25% 65
2024
Q2
$989K Sell
6,767
-17
-0.3% -$2.53K 0.25% 66
2024
Q1
$1.07M Sell
6,784
-82
-1% -$13.1K 0.28% 61
2023
Q4
$1.08M Sell
6,866
-10
-0.1% -$1.53K 0.31% 58
2023
Q3
$1.07M Buy
6,876
+9
+0.1% +$1.49K 0.36% 50
2023
Q2
$1.14M Buy
6,867
+54
+0.8% +$8.71K 0.35% 61
2023
Q1
$1.06M Sell
6,813
-19
-0.3% -$3.07K 0.34% 61
2022
Q4
$1.21M Hold
6,832
0.42% 58
2022
Q3
$1.12M Sell
6,832
-418
-6% -$70.7K 0.49% 46
2022
Q2
$1.29M Sell
7,250
-102
-1% -$18.2K 0.58% 40
2022
Q1
$1.3M Buy
7,352
+347
+5% +$59K 0.77% 38
2021
Q4
$1.2M Buy
+7,005
New +$1.15M 0.82% 31

Other funds holding JNJ

Waypoint Capital Advisors's JNJ Position: Q3 2024 in Review

Waypoint Capital Advisors increased its Johnson & Johnson (JNJ) stake by 5.3% in Q3 2024, buying an estimated $57.7K and bringing the position to 7,129 shares worth $1.16M. The position accounts for 0.25% of the portfolio, ranked #65.

Waypoint Capital Advisors first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.3M in Q1 2022. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Waypoint Capital Advisors held 7,129 shares of Johnson & Johnson worth $1.16M as of Q3 2024.
  • Waypoint Capital Advisors bought 362 Johnson & Johnson shares in Q3 2024, an estimated $57.7K.
  • Johnson & Johnson made up 0.25% of Waypoint Capital Advisors's portfolio in Q3 2024, its #65 holding.
  • Waypoint Capital Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
  • Waypoint Capital Advisors's Johnson & Johnson position peaked at $1.3M in Q1 2022.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Waypoint Capital Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.